T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
526
DELISTED
Marathon Oil Corporation
MRO
| $111M | 0.01% |
3,881,322
+3,066,237
| +376% | +$85M |
|
527
Paychex
PAYX
$43B
| $111M | 0.01% |
933,337
-46,176
| -5% | -$5.64M |
|
528
Krystal Biotech
KRYS
$9.86B
| $110M | 0.01% |
600,145
-58,473
| -9% | -$9.82M |
|
529
FTAI Aviation
FTAI
$22.4B
| $110M | 0.01% |
1,062,497
+194,534
| +22% | +$15.5M |
|
530
Monster Beverage
MNST
$91.3B
| $109M | 0.01% |
4,377,518
-10,207,554
| -70% | -$271M |
|
531
OR Royalties Inc
OR
$6.16B
| $108M | 0.01% |
6,938,313
+249,842
| +4% | +$4.05M |
|
532
Kosmos Energy
KOS
$1.48B
| $107M | 0.01% |
19,338,239
-1,809,336
| -9% | -$10.6M |
|
533
CoStar Group
CSGP
$12.5B
| $107M | 0.01% |
1,444,551
-122,648
| -8% | -$10.4M |
|
534
CBRE Group
CBRE
$42.9B
| $107M | 0.01% |
1,195,287
+15,393
| +1% | +$1.37M |
|
535
Arvinas
ARVN
$586M
| $106M | 0.01% |
3,988,869
-379,549
| -9% | -$12.1M |
|
536
Nutrien
NTR
$32.2B
| $106M | 0.01% |
2,073,944
-818,544
| -28% | -$44.8M |
|
537
Applovin
APP
$104B
| $105M | 0.01% |
1,260,934
+723,997
| +135% | +$56.2M |
|
538
The Ensign Group
ENSG
$10.6B
| $104M | 0.01% |
843,885
-26,133
| -3% | -$3.12M |
|
539
Duolingo
DUOL
$6.36B
| $104M | 0.01% |
499,729
+134,974
| +37% | +$27.6M |
|
540
Kilroy Realty
KRC
$4.3B
| $103M | 0.01% |
3,317,664
+154,916
| +5% | +$5.15M |
|
541
Ecolab
ECL
$77B
| $102M | 0.01% |
428,690
+8,511
| +2% | +$1.97M |
|
542
Apple Hospitality REIT
APLE
$3.75B
| $101M | 0.01% |
6,965,492
-433,181
| -6% | -$6.46M |
|
543
Lantheus
LNTH
$6.59B
| $99.6M | 0.01% |
1,240,603
-148,623
| -11% | -$10.9M |
|
544
Warrior Met Coal
HCC
$5.08B
| $98.6M | 0.01% |
1,570,375
+270,812
| +21% | +$17.5M |
|
545
Encompass Health
EHC
$12.2B
| $98.1M | 0.01% |
1,143,693
+603,174
| +112% | +$50.6M |
|
|
ITCI
546
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $97.8M | 0.01% |
1,428,410
+224,442
| +19% | +$15.6M |
|
|
AKRO
547
DELISTED
Akero Therapeutics
AKRO
| $97.3M | 0.01% |
4,146,351
+85,872
| +2% | +$1.84M |
|
548
PTC
PTC
$16B
| $97.1M | 0.01% |
534,681
-340,601
| -39% | -$61M |
|
|
B
549
Barrick Mining
B
$67B
| $96.2M | 0.01% |
5,768,889
+1,929,833
| +50% | +$32.8M |
|
550
Immunocore
IMCR
$1.74B
| $96M | 0.01% |
2,832,669
+395,085
| +16% | +$20.2M |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.